Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

20.11.2018 | short review | Ausgabe 4/2018 Open Access

memo - Magazine of European Medical Oncology 4/2018

ASCO Congress 2018: melanoma treatment

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 4/2018
Autor:
Prof. Dr. Erika Richtig

Summary

The 2018 ASCO Annual Meeting provided a closer look on the details of studies already presented. In melanoma, the interest was on neoadjuvant treatment options with high pathological response rates as well as updates on large phase III studies in stage IV disease. Further new targets were discussed focusing on additional drugs to a PD-1 backbone treatment.
Another focus was on Merkel cell carcinoma and basal cell carcinomas, giving new data on PD-1 antibody treatments as well as on vismodegib as neoadjuvant therapy.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 4/2018

memo - Magazine of European Medical Oncology 4/2018 Zur Ausgabe